Ocular therapeutix inc.

Major-Pharmaceuticals

OCUL


15 Crosby Drive
Bedford , MA 01730

Executive/
Director

Price

  • Last Close
  • $ 9.65
    $ +0.47 5.07 %
    Dec 6, 2024
  • 52-Week High/Low
  • $10.93 - $2.08
  • YTD
  • 116.3%

  • Trading Volume
  • 11,780
  • Market Cap Full
  • $ 766.4M
  • Shares Outstanding
  • 79.4M
    Nov 3, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 78.5% 3.1% 10.9% 46.3% -0.3% -5% -20.7% -29% 87.5% 104%
Q2 -49.9% -48.8% -0.1% 4.8% 8.6% 4% -13.6% -18.8% -2.1% -2.8%
Q3 -33.1% 38.8% -33.3% 4.6% -36.4% 8% -29.1% 3.2% -39.2% -
Q4 -33.4% 21.8% -29.4% -44% 29% 172% -30.7% -32.3% 51.2% -
J F M A M J J A S O N D
2024 9% 107% -9.5% -7.1% - - - - - - - -
2023 39.2% 54.5% -12.8% 17.7% 3.2% -19.4% -12% -16.7% -16.9% -9.2% -13% 79.8%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%-60%-11%-47%-11%-1%425%-66%-60%59%116%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.35 0.44 0.58 -0.4 -0.45 -0.41 -0.24 -0.22 -0.39
Q2 0.45 0.46 0.64 -0.37 -0.57 -0.64 -0.25 -0.25 -0.26
Q3 0.47 0.39 0.54 -0.38 -0.45 -0.21 -0.23 -0.31 -0.25
Q4 0.43 0.52 0.44 -0.42 -0.44 -1.3 -0.26 -0.19 -
A 1.7 1.8 2.2 -1.6 -1.9 -2.6 -1 -1 -0.9

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 42.8 52.6 76.1 76.8 77.5
Jun 37.3 42.8 53.4 76.3 76.8 77.5
Sep 38.6 47.2 63 76.6 77 79.4
Dec 41.1 48.1 71.4 76.6 77 79.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 2.5 4 2 2 -
Fixed Asset Turnover 4.3 4.9 1.7 0.3 0.1
Total Asset Turnover 0.3 0.2 0.1 0.1 -
Leverage
Debt Ratio 0.2 0.1 0.1 0.4 0.5
Debt – Equity Ratio 0.7 0.3 0.2 -6.3 0.7
Interest Coverage 9.9 1.1 -0.7 - -59
Equity multiplier 0.3 0.1 0.1 -3 0.5